An EHR-derived model more accurately estimated cerebrovascular and cardiovascular mortality than did the Framingham Risk Score (FRS), highlighting the potential to use EHRs for clinical and policy purposes.

The FDA determined that a researcher in Medtronic’s CoreValve pivotal trial failed to adequately address what inspectors had identified as “objectionable conditions.” The agency requested “prompt corrective actions” and warned that it could initiate disqualification proceedings.

In this issue of Cardiovascular Business, we examine the growing trend of MD/MBAs. Traditionally, physicians who chose this path first earned their MD, practiced for several years and then pursued an MBA. While a handful of MD/MBA dual-degree programs existed two decades ago, the numbers have reached an estimated 65 today.

The clinical and business aspects of medicine traditionally have been seen as polar opposites, with MDs monitoring the health of the patient and MBAs taking the fiscal pulse of the institution. More and more, though, cardiologists have turned to additional education to become adept at both, a trend that broadens their opportunities and also may benefit peers and patients.

EHRs lighten administrative burden, but practices must roll out implementation carefully and anticipate bumps in the road.

The American College of Cardiology's (ACC) clinical resources, educational programming, patient education tools and a suite of hospital and outpatient registries are among the offerings that members say are of the most value.

An administrator and two cath lab directors share tips on how to preserve good will and restore a damaged reputation.

Truven Health Analytics unveiled its equivalent to the Oscars with the release of its annual list of the top 100 hospitals based on their overall organizational performance.